Literature DB >> 21477649

Discoidin domain receptor 2 is a critical regulator of epithelial-mesenchymal transition.

Logan A Walsh1, Ali Nawshad, Damian Medici.   

Abstract

Discoidin domain receptor 2 (DDR2) is a collagen receptor that is expressed during epithelial-mesenchymal transition (EMT), a cellular transformation that mediates many stages of embryonic development and disease. However, the functional significance of this receptor in EMT is unknown. Here we show that Transforming Growth Factor-beta1 (TGF-β1), a common stimulator of EMT, promotes increased expression of type I collagen and DDR2. Inhibiting expression of COL1A1 or DDR2 with siRNA is sufficient to perturb activity of the NF-κB and LEF-1 transcription factors and to inhibit EMT and cell migration induced by TGF-β1. Furthermore, knockdown of DDR2 expression with siRNA inhibits EMT directly induced by type I collagen. These data establish a critical role for type I collagen-dependent DDR2 signaling in the regulation of EMT.
Copyright © 2011 International Society of Matrix Biology. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21477649      PMCID: PMC3114285          DOI: 10.1016/j.matbio.2011.03.007

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  27 in total

1.  Down-regulation of E-cadherin gene expression by collagen type I and type III in pancreatic cancer cell lines.

Authors:  A Menke; C Philippi; R Vogelmann; B Seidel; M P Lutz; G Adler; D Wedlich
Journal:  Cancer Res       Date:  2001-04-15       Impact factor: 12.701

Review 2.  TGF-beta and epithelial-to-mesenchymal transitions.

Authors:  Jiri Zavadil; Erwin P Böttinger
Journal:  Oncogene       Date:  2005-08-29       Impact factor: 9.867

Review 3.  An overview of epithelio-mesenchymal transformation.

Authors:  E D Hay
Journal:  Acta Anat (Basel)       Date:  1995

Review 4.  TGF-beta signaling in cancer--a double-edged sword.

Authors:  R J Akhurst; R Derynck
Journal:  Trends Cell Biol       Date:  2001-11       Impact factor: 20.808

5.  The mechanism of palatal clefting in the Col11a1 mutant mouse.

Authors:  I O Lavrin; W McLean; R E Seegmiller; B R Olsen; E D Hay
Journal:  Arch Oral Biol       Date:  2001-09       Impact factor: 2.633

6.  Links between signal transduction, transcription and adhesion in epithelial bud development.

Authors:  Colin Jamora; Ramanuj DasGupta; Pawel Kocieniewski; Elaine Fuchs
Journal:  Nature       Date:  2003-03-20       Impact factor: 49.962

Review 7.  The basics of epithelial-mesenchymal transition.

Authors:  Raghu Kalluri; Robert A Weinberg
Journal:  J Clin Invest       Date:  2009-06       Impact factor: 14.808

Review 8.  The tumor microenvironment: a critical determinant of neoplastic evolution.

Authors:  Léon C L T van Kempen; Dirk J Ruiter; Goos N P van Muijen; Lisa M Coussens
Journal:  Eur J Cell Biol       Date:  2003-11       Impact factor: 4.492

9.  TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT).

Authors:  Hidenori Kasai; Jeremy T Allen; Roger M Mason; Takashi Kamimura; Zhi Zhang
Journal:  Respir Res       Date:  2005-06-09

10.  Epithelial-mesenchymal transition in primary human bronchial epithelial cells is Smad-dependent and enhanced by fibronectin and TNF-alpha.

Authors:  Joana Câmara; Gabor Jarai
Journal:  Fibrogenesis Tissue Repair       Date:  2010-01-05
View more
  29 in total

1.  Targeting of Discoidin Domain Receptor 2 (DDR2) Prevents Myofibroblast Activation and Neovessel Formation During Pulmonary Fibrosis.

Authors:  Hu Zhao; Huan Bian; Xin Bu; Shuya Zhang; Pan Zhang; Jiangtian Yu; Xiaofeng Lai; Di Li; Chuchao Zhu; Libo Yao; Jin Su
Journal:  Mol Ther       Date:  2016-05-27       Impact factor: 11.454

Review 2.  The barrier hypothesis and Oncostatin M: Restoration of epithelial barrier function as a novel therapeutic strategy for the treatment of type 2 inflammatory disease.

Authors:  Kathryn L Pothoven; Robert P Schleimer
Journal:  Tissue Barriers       Date:  2017-06-13

Review 3.  Discoidin domain receptor tyrosine kinases: new players in cancer progression.

Authors:  Rajeshwari R Valiathan; Marta Marco; Birgit Leitinger; Celina G Kleer; Rafael Fridman
Journal:  Cancer Metastasis Rev       Date:  2012-06       Impact factor: 9.264

Review 4.  Discoidin domain receptors: a proteomic portrait.

Authors:  Leo K Iwai; Maciej T Luczynski; Paul H Huang
Journal:  Cell Mol Life Sci       Date:  2014-04-05       Impact factor: 9.261

5.  Exploiting polypharmacology for drug target deconvolution.

Authors:  Taranjit Singh Gujral; Leonid Peshkin; Marc W Kirschner
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-19       Impact factor: 11.205

6.  Functional Precision Medicine Identifies Novel Druggable Targets and Therapeutic Options in Head and Neck Cancer.

Authors:  Chang Xu; Olga Nikolova; Ryan S Basom; Ryan M Mitchell; Reid Shaw; Russell D Moser; Heuijoon Park; Kay E Gurley; Michael C Kao; Carlos L Green; Franz X Schaub; Robert L Diaz; Hallie A Swan; In S Jang; Justin Guinney; Vijayakrishna K Gadi; Adam A Margolin; Carla Grandori; Christopher J Kemp; Eduardo Méndez
Journal:  Clin Cancer Res       Date:  2018-03-29       Impact factor: 12.531

7.  Overexpression of DDR2 contributes to cell invasion and migration in head and neck squamous cell carcinoma.

Authors:  Jinke Xu; Wei Lu; Senlin Zhang; Chuchao Zhu; Tingting Ren; Tong Zhu; Hu Zhao; Yanpu Liu; Jin Su
Journal:  Cancer Biol Ther       Date:  2014-02-20       Impact factor: 4.742

8.  Hepatic Stellate Cell-Macrophage Crosstalk in Liver Fibrosis and Carcinogenesis.

Authors:  Michitaka Matsuda; Ekihiro Seki
Journal:  Semin Liver Dis       Date:  2020-04-02       Impact factor: 6.115

9.  Genetic landscape of metastatic and recurrent head and neck squamous cell carcinoma.

Authors:  Matthew L Hedberg; Gerald Goh; Simion I Chiosea; Julie E Bauman; Maria L Freilino; Yan Zeng; Lin Wang; Brenda B Diergaarde; William E Gooding; Vivian W Y Lui; Roy S Herbst; Richard P Lifton; Jennifer R Grandis
Journal:  J Clin Invest       Date:  2015-11-30       Impact factor: 14.808

Review 10.  Discoidin domain receptors in disease.

Authors:  Corina M Borza; Ambra Pozzi
Journal:  Matrix Biol       Date:  2013-12-19       Impact factor: 11.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.